Concomitant lung metastasis in patients with advanced hepatocellular carcinoma

World Journal of Gastroenterology

Volumn 18, Issue 20, 2012, Pages 2533-2539

  Yang, Tian ^a   Lu, Jun Hua ^a   Lin, Chuan ^a   Shi, Song ^a   Chen, Ting Hao ^b   Zhao, Rong Hua ^c   Wang, Yi ^a   Wu, Meng Chao ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

^b First People's Hospital of Ziyang   (China)

^c ROYAL UNIVERSITY HOSPITAL   (Canada)

Author keywords

Hepatocellular carcinoma; Lung metastasis; Prognosis; Prognostic factor; Survival

Indexed keywords

SORAFENIB;

ADULT; ADVANCED CANCER; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CAUSE OF DEATH; CHEMOEMBOLIZATION; CHILD PUGH SCORE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FOLLOW UP; GAMMA KNIFE RADIOSURGERY; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; LIVER VEIN THROMBOSIS; LUNG METASTASIS; MAJOR CLINICAL STUDY; MALE; METASTASIS RESECTION; MIDDLE AGED; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; OVERALL SURVIVAL; PORTAL VEIN THROMBOSIS; PULMONARY METASTASECTOMY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; TUMOR LOCALIZATION; TUMOR THROMBUS; TUMOR VOLUME; KAPLAN MEIER METHOD; LIVER TUMOR; LUNG TUMOR; METASTASIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL;

ADULT; CARCINOMA, HEPATOCELLULAR; COMBINED MODALITY THERAPY; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 84871917557     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v18.i20.2533     Document Type: Article

References (20)

1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007; 132: 2557-2576
2. Rahbari NN, Mehrabi A, Mollberg NM, Müller SA, Koch M, Büchler MW, Weitz J. Hepatocellular carcinoma: current management and perspectives for the future. Ann Surg 2011; 253: 453-469
3. Natsuizaka M, Omura T, Akaike T, Kuwata Y, Yamazaki K, Sato T, Karino Y, Toyota J, Suga T, Asaka M. Clinical features of hepatocellular carcinoma with extrahepatic metastases. J Gastroenterol Hepatol 2005; 20: 1781-1787
4. Zhang SM, Zeng ZC, Tang ZY, Sun J, Cheng JM, Liu R, Wang P, Zhang BH. Prognostic analysis of pulmonary metastases from hepatocellular carcinoma. Hepatol Int 2008; 2: 237-243
5. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodés J. Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver. J Hepatol 2001; 35: 421-430
6. Lam CM, Lo CM, Yuen WK, Liu CL, Fan ST. Prolonged survival in selected patients following surgical resection for pulmonary metastasis from hepatocellular carcinoma. Br J Surg 1998; 85: 1198-1200
7. Nakagawa T, Kamiyama T, Nakanishi K, Yokoo H, Kamachi H, Matsushita M, Todo S. Pulmonary resection for metastases from hepatocellular carcinoma: factors influencing prognosis. J Thorac Cardiovasc Surg 2006; 131: 1248-1254
8. Tomimaru Y, Sasaki Y, Yamada T, Eguchi H, Takami K, Ohigashi H, Higashiyama M, Ishikawa O, Kodama K, Imaoka S. The significance of surgical resection for pulmonary metastasis from hepatocellular carcinoma. Am J Surg 2006; 192: 46-51
9. Kuo SW, Chang YL, Huang PM, Hsu HH, Chen JS, Lee JM, Lee PH, Lee YC. Prognostic factors for pulmonary metastasectomy in hepatocellular carcinoma. Ann Surg Oncol 2007; 14: 992-997
10. Chen F, Sato K, Fujinaga T, Sonobe M, Shoji T, Sakai H, Miyahara R, Bando T, Okubo K, Hirata T, Date H. Pulmonary resection for metastases from hepatocellular carcinoma. World J Surg 2008; 32: 2213-2217
11. Kawamura M, Nakajima J, Matsuguma H, Horio H, Miyoshi S, Nakagawa K, Fujisawa T, Kobayashi K. Surgical outcomes for pulmonary metastases from hepatocellular carcinoma. Eur J Cardiothorac Surg 2008; 34: 196-199
12. Kwon JB, Park K, Kim YD, Seo JH, Moon SW, Cho DG, Kim YW, Kim DG, Yoon SK, Lim HW. Clinical outcome after pulmonary metastasectomy from primary hepatocellular carcinoma: analysis of prognostic factors. World J Gastroenterol 2008; 14: 5717-5722
13. Yang T, Zhang J, Lu JH, Yang LQ, Yang GS, Wu MC, Yu WF. A new staging system for resectable hepatocellular carcinoma: comparison with six existing staging systems in a large Chinese cohort. J Cancer Res Clin Oncol 2011; 137: 739-750
14. Dawson LA. The evolving role of radiation therapy in hepatocellular carcinoma. Cancer Radiother 2008; 12: 96-101
15. Cárdenes HR. Role of stereotactic body radiotherapy in the management of primary hepatocellular carcinoma. Rationale, technique and results. Clin Transl Oncol 2009; 11: 276-283
16. Ma S, Jiao B, Liu X, Yi H, Kong D, Gao L, Zhao G, Yang Y, Liu X. Approach to radiation therapy in hepatocellular carcinoma. Cancer Treat Rev 2010; 36: 157-163
17. Tse RV, Guha C, Dawson LA. Conformal radiotherapy for hepatocellular carcinoma. Crit Rev Oncol Hematol 2008; 67: 113-123
18. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Häussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008; 359: 378-390
19. Colombo M. Sorafenib in advanced hepatocellular carcinoma: a further step toward personalized therapy of liver cancer. Gastroenterology 2009; 136: 1832-1835
20. Zhao JD, Liu J, Ren ZG, Gu K, Zhou ZH, Li WT, Chen Z, Xu ZY, Liu LM, Jiang GL. Maintenance of Sorafenib following combined therapy of three-dimensional conformal radiation therapy/intensity-modulated radiation therapy and transcatheter arterial chemoembolization in patients with locally advanced hepatocellular carcinoma: a phase I/II study. Radiat Oncol 2010; 5: 12